Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack. Research Beam Model: Research Beam Product ID: 2105046 5370 USD New
Peripheral Artery Disease Market by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Peripheral Accessories) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Peripheral Artery Disease Market by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Peripheral Accessories) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Medical Devices
  • Published On : September  2017
  • Pages : 150
 
 

Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.

The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a CAGR of 6.8% during the study period. The growth in geriatric population coupled with increase in incidence of peripheral artery disease are the major factors that drive the growth of the peripheral artery disease market. In addition, introduction of advanced interventional products such as drug coated balloons also boost the market growth. However, restenosis (reoccurrence of the disease post treatment) majorly restraints the market growth.

The global peripheral artery disease market is segmented on the basis of type and region. Based on type, the market is divided into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the market through 2016–2023 that helps identify the upcoming market opportunities.
  • Recent industry trends and developments and the future opportunities are also covered.
  • Extensive knowledge about the key market players and their strategies is provided.
  • Comprehensive analysis of the various factors that drive and restrain the growth of the market is provided.

Key Market Segments

By Type

  • Peripheral Angioplasty Balloons
    • Old/Normal Balloons
    • Cutting and Scoring Balloons
    • Drug-Coated Balloons
  • Peripheral Stents
    • Self-expandable
    • Balloon-expandable
    • Covered
    • Drug-eluting Stents
  • Peripheral Catheters
    • Angiography Catheters
    • Guiding Catheters
  • Inferior Vena Cava (IVC) Filters
    • Permanent Filters
    • Retrievable Filters
  • Plaque Modification Devices
    • Thrombectomy Devices
      • Mechanical Thrombectomy Devices
      • Aspiration Thrombectomy Devices
      • Rheolytic Thrombectomy Devices
    • Atherectomy Devices
  • Hemodynamic Flow Alteration Devices
    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  • Peripheral Accessories
    • Vascular Closure Devices
    • Introducer Sheaths
    • Guidewires
    • Balloon Inflation Devices

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key market players

The key players operating in this market include

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical
  • Cardinal Health, Inc.
  • C. R. Bard, Inc.
  • Medtronic plc
  • Terumo Corporation
  • The Spectranetics Corporation
  • AngioDynamics, Inc.
  • BIOTRONIK
  • B. Braun Melsungen AG

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Growing geriatric population and increasing prevalence of chronic diseases
3.3.1.2. Introduction of advanced interventional products
3.3.1.3. Improvement of healthcare infrastructure in developing countries
3.3.1.4. Improved insurance and reimbursement

3.3.2. Restraints

3.3.2.1. Restenosis
3.3.2.2. Stringent approval process for stents

3.3.3. Opportunities

3.3.3.1. Market opportunities in developing countries

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

CHAPTER 4 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PERIPHERAL ANGIOPLASTY BALLOONS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Old/Normal Balloons

4.2.4.1. Market size and forecast

4.2.5. Cutting and Scoring Balloons

4.2.5.1. Market size and forecast

4.2.6. Drug-Coated Balloons

4.2.6.1. Market size and forecast

4.3. PERIPHERAL STENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Self-expandable

4.3.4.1. Market size and forecast

4.3.5. Balloon-expandable

4.3.5.1. Market size and forecast

4.3.6. Covered stents

4.3.6.1. Market size and forecast

4.3.7. Drug-eluting Stents

4.3.7.1. Market size and forecast

4.4. ANGIOPLASTY CATHETERS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Angiography Catheters

4.4.4.1. Market size and forecast

4.4.5. Guiding Catheters

4.4.5.1. Market size and forecast

4.5. INFERIOR VENA CAVA (IVC) FILTERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Permanent Filters

4.5.4.1. Market size and forecast

4.5.5. Retrievable Filters

4.5.5.1. Market size and forecast

4.6. PLAQUE MODIFICATION DEVICES

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Thrombectomy Devices

4.6.4.1. Market size and forecast
4.6.4.2. Mechanical Thrombectomy Devices
4.6.4.3. Market size and forecast
4.6.4.4. Aspiration Thrombectomy Devices
4.6.4.5. Market size and forecast
4.6.4.6. Rheolytic Thrombectomy Devices
4.6.4.7. Market size and forecast

4.6.5. Atherectomy Devices

4.6.5.1. Market size and forecast

4.7. HEMODYNAMIC FLOW ALTERATION DEVICES

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. Embolic Protection Devices

4.7.4.1. Market size and forecast

4.7.5. Chronic Total Occlusion Devices

4.7.5.1. Market size and forecast

4.8. PERIPHERAL ACCESSORIES

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
4.8.4. Peripheral vascular Closure Devices

4.8.4.1. Market size and forecast

4.8.5. Introducer Sheaths

4.8.5.1. Market size and forecast

4.8.6. Guidewires

4.8.6.1. Market size and forecast

4.8.7. Balloon Inflation Devices

4.8.7.1. Market size and forecast

CHAPTER 5 PERIPHERAL ARTERY DISEASE MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.
5.2.5. Canada
5.2.6. Mexico

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany
5.3.5. France
5.3.6. UK
5.3.7. Italy
5.3.8. Spain
5.3.9. Rest of Europe

5.4. ASIA-PACFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan
5.4.5. China
5.4.6. India
5.4.7. Australia
5.4.8. Rest of Asia-Pacific

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil
5.5.5. South Africa
5.5.6. Saudi Arabia
5.5.7. Rest of LAMEA

CHAPTER 6 COMPANY PROFILES

6.1. ABBOTT LABORATORIES

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. BOSTON SCIENTIFIC CORPORATION

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. COOK

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves and developments

6.4. CARDINAL HEALTH, INC.

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. C. R. BARD, INC.

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. MEDTRONIC PLC

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. TERUMO CORPORATION

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. SPECTRANETICS

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments

6.9. ANGIODYNAMICS

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments

6.10. BIOTRONIK

6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments

6.11. B. BRAUN MELSUNGEN AG

6.11.1. Company overview
6.11.2. Operating business segments
6.11.3. Business performance
6.11.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 2. PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 3. PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 4. PERIPHERAL STENTS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 5. PERIPHERAL STENTS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 6. ANGIOPLASTY CATHETERS, BY TYPE, 2016-2023, ($MILLION)
TABLE 7. ANGIOPLASTY CATHETERS, BY REGION, 2016-2023, ($MILLION)
TABLE 8. INFERIOR VENA CAVA (IVC) FILTERS, BY TYPE, 2016-2023, ($MILLION)
TABLE 9. INFERIOR VENA CAVA (IVC) FILTERS, BY REGION, 2016-2023, ($MILLION)
TABLE 10. PLAQUE MODIFICATION DEVICES, BY TYPE, 2016-2023, ($MILLION)
TABLE 11. PLAQUE MODIFICATION DEVICES, BY REGION, 2016-2023, ($MILLION)
TABLE 12. THROMBECTOMY DEVICES, BY TYPE, 2016-2023, ($MILLION)
TABLE 13. THROMBECTOMY DEVICES, BY REGION, 2016-2023, ($MILLION)
TABLE 14. HEMODYNAMIC FLOW ALTERATION DEVICES, BY TYPE, 2016-2023, ($MILLION)
TABLE 15. HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2016-2023, ($MILLION)
TABLE 16. PERIPHERAL ACCESSORIES MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 17. PERIPHERAL ACCESSORIES MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 18. PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 19. NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 20. NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 21. U.S. PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 22. CANADA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 23. MEXICO PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 24. EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 25. EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 26. GERMANY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 27. FRANCE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 28. UK PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 29. ITALY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 30. SPAIN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 31. REST OF EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 32. ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 33. ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 34. JAPAN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 35. CHINA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 36. INDIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 37. AUSTRALIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 38. REST OF ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 39. LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 40. LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 41. BRAZIL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 42. SOUTH AFRICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 43. SAUDI ARABIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 44. REST OF LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 45. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 46. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 47. COOK: COMPANY SNAPSHOT
TABLE 48. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 49. C. R. BARD: COMPANY SNAPSHOT
TABLE 50. MEDTRONIC: COMPANY SNAPSHOT
TABLE 51. TERUMO: COMPANY SNAPSHOT
TABLE 52. SPECTRANETICS: COMPANY SNAPSHOT
TABLE 53. ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 54. BIOTRONIK: COMPANY SNAPSHOT
TABLE 55. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. PERIPHERAL ARTERY DISEASE MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (20142016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. TOP INVESTMENT POCKETS
FIGURE 6. IMPACT ANALYSIS, 2016
FIGURE 7. MARKET SHARE ANALYSIS, 2016
FIGURE 8. TOTAL NUMBER OF CLINICAL TRIALS IN PERIPHERAL ARTERY DISEASE MARKET
FIGURE 9. OLD/NORMAL BALLOONS MARKET, 2016-2023 ($MILLION)
FIGURE 10. CUTTING AND SCORING BALLOONS MARKET, 2016-2023 ($MILLION)
FIGURE 11. DRUG-COATED BALLOONS MARKET, 2016-2023 ($MILLION)
FIGURE 12. SELF-EXPANDABLE MARKET, 2016-2023 ($MILLION)
FIGURE 13. BALLOON-EXPANDABLE MARKET, 2016-2023 ($MILLION)
FIGURE 14. COVERED STENTS MARKET, 2016-2023 ($MILLION)
FIGURE 15. DRUG-ELUTING STENTS MARKET, 2016-2023 ($MILLION)
FIGURE 16. ANGIOGRAPHY CATHETERS MARKET, 2016-2023 ($MILLION)
FIGURE 17. GUIDING CATHETERS MARKET, 2016-2023 ($MILLION)
FIGURE 18. PERMANENT FILTERS MARKET, 2016-2023 ($MILLION)
FIGURE 19. RETRIEVABLE FILTERS MARKET, 2016-2023 ($MILLION)
FIGURE 20. MECHANICAL THROMBECTOMY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 21. MECHANICAL THROMBECTOMY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 22. MECHANICAL THROMBECTOMY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 23. ATHERECTOMY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 24. EMBOLIC PROTECTION DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 25. CHRONIC TOTAL OCCLUSION DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 26. PERIPHERAL VASCULAR CLOSURE DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 27. INTRODUCER SHEATHS MARKET, 2016-2023 ($MILLION)
FIGURE 28. GUIDEWIRES MARKET, 2016-2023 ($MILLION)
FIGURE 29. BALLOON INFLATION DEVICES MARKET, 2016-2023 ($MILLION)